EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Remote versus in‐person cognitive testing: the impact of visit modality on longitudinal cognitive outcomes in older adults

Yu Leng, Yingnan He, Dawn Mechanic‐Hamilton, Lindsay R. Clark, Bonnie C. Sachs, Melissa Lamar, Zachary T. Beattie, Andrew J. Saykin, Lisa L. Barnes, Kevin Duff, Ana W. Capuano, Sudeshna Das

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70530 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction The COVID‐19 pandemic accelerated adoption of remote cognitive assessments in Alzheimer's disease (AD) research, yet comparability across visit modalities remains unclear. This study evaluated whether visit modality influenced cognitive performance. Methods We analyzed 27,144 visits from 13,219 participants across 37 Alzheimer's Disease Research Centers (March 2020 to December 2024), including in‐person, telephone, and video visits, among adults aged ≥65 years. Linear mixed‐effects models examined associations between visit modality and cognitive performance. Results Remote assessments comprised 20.8% of visits and were associated with slightly higher Montreal Cognitive Assessment scores than in‐person visits for both telephone and video modalities ( p < 2.0E‐16; Cohen's d = 0.21 to 0.26). Domain analyses showed modestly higher memory and attention performance during remote visits, with minimal differences in executive function or language. Discussion Remote cognitive assessments showed largely comparable performance to in‐person testing, supporting their validity and potential to improve accessibility and inclusiveness in AD research.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →